Tumor recurrence in patients treated with direct-acting antivirals for hepatitis C following curative therapy: a cause for concern?

被引：0
|
作者：
Evren, Sevan [1 ]
Wong, David K. H. [1 ]
机构：
[1] Univ Toronto, Toronto Ctr Liver Dis, 200 Elizabeth St,EN9-228, Toronto, ON M5G 2C4, Canada
来源：
TRANSLATIONAL CANCER RESEARCH | 2016年 / 5卷
关键词：
D O I：
10.21037/tcr.2016.08.06
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S233 / S236
页数：4
相关论文
共 50 条
  • [1] Hepatitis B Reactivation in Patients Treated with Direct-Acting Antivirals for Hepatitis C
    Toka, Bilal
    Koksal, Aydin Seref
    Dertli, Ramazan
    Sirin, Goktug
    Fidan, Sami
    Ulger, Yakup
    Harmandar, Ferda
    Yildirim, Abdullah Emre
    Eminler, Ahmet Tarik
    Asil, Mehmet
    Kayar, Yusuf
    Biyik, Murat
    Kuran, Sedef
    Uslan, Mustafa Ihsan
    Hulagu, Sadettin
    DIGESTIVE DISEASES, 2022, : 635 - 643
  • [2] Incidence of depression in patients with hepatitis C treated with direct-acting antivirals
    Egmond, Elfi
    Marino, Zoe
    Navines, Ricard
    Oriolo, Giovanni
    Pla, Anna
    Bartres, Concepcio
    Lens, Sabela
    Forns, Xavier
    Martin-Santos, Rocio
    BRAZILIAN JOURNAL OF PSYCHIATRY, 2020, 42 (01) : 72 - 76
  • [3] Therapy completion of direct-acting antivirals for hepatitis C
    Machado, Marina A. A.
    Moura, Cristiano S.
    Klein, Marina
    Carleton, Bruce
    Winthrop, Kevin
    Abrahamowicz, Michal
    Feld, Jordan
    Curtis, Jeffrey R.
    Bernatsky, Sasha
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 498 - 499
  • [4] Hepatocellular Carcinoma Occurrence and Recurrence in Hepatitis C-infected Patients Treated with Direct-acting Antivirals
    Syed, Taseen
    Fazili, Javid
    Ali, Ijlal Akbar
    Zhao, Daniel
    Hughes, Diane
    Mahmood, Sultan
    CUREUS, 2018, 10 (06):
  • [5] Risk of hepatitis B reactivation in patients treated with direct-acting antivirals for hepatitis C
    Ioanna Aggeletopoulou
    Christos Konstantakis
    Spilios Manolakopoulos
    Christos Triantos
    World Journal of Gastroenterology, 2017, (24) : 4317 - 4323
  • [6] Risk of hepatitis B reactivation in patients treated with direct-acting antivirals for hepatitis C
    Aggeletopoulou, Ioanna
    Konstantakis, Christos
    Manolakopoulos, Spilios
    Triantos, Christos
    WORLD JOURNAL OF GASTROENTEROLOGY, 2017, 23 (24) : 4317 - 4323
  • [7] Evaluation of fibrosis in chronic hepatitis C patients treated with direct-acting antivirals
    Tufan, Ayse Gokcen
    Hakim, Gozde Dervis
    Akar, Harun
    Akarsu, Mesut
    HEPATOLOGY FORUM, 2020, 1 (02): : 53 - 58
  • [8] Direct-Acting Antivirals Are not Associated With Early Tumor Recurrence After Curative Treatments in Hepatitis C-related Hepatocellular Carcinoma
    Chan, Yin
    Maclennan, Samuel
    Dixon, Elijah
    Wong, Jason
    Swain, Mark
    Coffin, Carla
    Burak, Kelly
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S521 - S523
  • [9] Future of hepatitis C therapy: development of direct-acting antivirals
    Dore, Gregory J.
    Matthews, Gail V.
    Rockstroh, Juergen
    CURRENT OPINION IN HIV AND AIDS, 2011, 6 (06) : 508 - 513
  • [10] Benefits of Direct-Acting Antivirals for Hepatitis C
    Lok, Anna S.
    Chung, Raymond T.
    Vargas, Hugo E.
    Kim, Arthur Y.
    Naggie, Susanna
    Powderly, William G.
    ANNALS OF INTERNAL MEDICINE, 2017, 167 (11) : 812 - +
12345